The nanocomposite inhibited macrophage activation-related inactive rhomboid protein 2/TNF-α converting enzyme/TNF-α signaling and restored nuclear factor erythroid-2-related factor 2 to relieve Listeria monocytogenes-induced metabolic disorder and septicemia-associated systemic inflammation. The gene discussed is TNF; the disease is Sepsis.